Oral glucocorticoid patterns use in moderate to severe active SLE: insights from the Spanish SPOCS data.

IF 3.5 2区医学 Q1 RHEUMATOLOGY

Lupus Science & Medicine Pub Date : 2025-07-22 DOI:10.1136/lupus-2025-001597

Iñigo Rua-Figueroa, Ricard Cervera, Mercedes Freire-González, Ana Isabel Turrión Nieves, Josefina Cortés-Hernández, Iván Castellvi, Julia Barbado Ajo, Tarek Salman, Jaime Calvo Alén, Nuria Lozano-Rivas, Norberto Ortego-Centeno, Monserrat Diaz-Encarnación, Bo Ding, Marta Galvez-Fernandez, Noemí Bahamontes-Rosa, José María Pego-Reigosa

引用次数: 0

查看原文本刊更多论文

口服糖皮质激素模式用于中重度活动性SLE：来自西班牙SPOCS数据的见解

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Lupus Science & Medicine RHEUMATOLOGY-

CiteScore

5.30

自引率

7.70%

发文量

审稿时长

15 weeks

期刊介绍： Lupus Science & Medicine is a global, peer reviewed, open access online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases. It is the first lupus-specific open access journal in the world and was developed in response to the need for a barrier-free forum for publication of groundbreaking studies in lupus. The journal publishes research on lupus from fields including, but not limited to: rheumatology, dermatology, nephrology, immunology, pediatrics, cardiology, hepatology, pulmonology, obstetrics and gynecology, and psychiatry.